1. World Health Organisation (WHO). Global Health Observatory (GHO) data. Raised blood pressure.. URL: https://www.who.int/gho/ncd/risk_factors/blood_pressure_prevalence_text/en/
2. Joffres M, Falaschetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3(8):e003423. doi:10.1136/bmjopen-2013-003423
3. Saedon NI, Tan MP, Frith J. The prevalence of orthostatic hypotension: a systematic review and meta-analysis. Gerontol A Biol Sci Med Sci. 2020;75(1):117–122. doi:10.1093/gerona/gly188
4. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS et al. ACCF Task Force. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2011;123(21):2434–2506. doi: 10.1161/CIR.0b013e31821daaf6. Epub 2011 Apr 25.
5. Masaki KH, Schatz IJ, Burchfiel CM, Sharp DS, Chiu D, Foley D et al. Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation. 1998;98(21):2290–2295.
6. Di Stefano C, Milazzo V, Totaro S, Sobrero G, Ravera A, Milan A et al. Orthostatic hypotension in a cohort of hypertensive patients referring to a hypertension clinic. J Hum Hypertens. 2015;29(10):599–603. doi:10.1038/jhh.2014.130
7. Остроумова О. Д., Черняева М. С., Петрова М. М., Головина О. Д. Ортостатическая гипотензия: определение, патофизиология, классификация, прогностические аспекты, диагностика и лечение. Рациональная фармакотерапия в кардиологии. 2018;14(5):747–756. doi.org/10.20996/1819-6446-2018-14-5-747-756.
8. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009;374(9696):1196–1208. doi:10.1016/S0140-6736(09)61460-4
9. Crimmins EM. Lifespan and healthspan: past, present, and promise. Gerontologist. 2015;55(6):901–911. doi:10.1093/geront/gnv130
10. Franceschi C, Passarino G, Mari D, Monti D. Centenarians as a 21st century healthy aging model: A legacy of humanity and the need for a world-wide consortium (WWC100+). Mech Ageing Dev. 2017;165(PtB):55–58. doi:10.1016/j.mad.2017.06.002.
11. Evert J, Lawler E, Bogan H, Perls T. Morbidity profiles of centenarians: survivors, delayers, and escapers. J Gerontol A Biol Sci Med Sci. 2003;58(3):232–237.
12. Schatz IJ, Masaki K, Yano K, Chen R, Rodriguez BL, Curb JD. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet. 2001;358(9279):351–355.
13. Schupf N, Costa R, Luchsinger J, Tang MX, Lee JH, Mayeux R. Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc. 2005;53(2): 219–226.
14. Oates DJ, Berlowitz DR, Glickman ME, Silliman RA, Borzecki AM. Blood pressure and survival in the oldest old. J Am Geriatr Soc. 2007;55(3):383–388. doi:10.1111/j.1532–5415.2007.01069.x
15. Denardo SJ, Gong Y, Nichols WW, Messerli FH, Bavry AA, Cooper-Dehoff RM et al. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST Substudy. Am J Med. 2010;123(8):719–726. doi:10.1016/j.amjmed.2010.02.014